Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer

MLA

Pietro Di Marino, et al. “Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer.” OncoTargets and Therapy, vol. 15, Apr. 2022, pp. 407–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........05bc834a89a15d1a8d0682b7b23a4687&authtype=sso&custid=ns315887.

APA

Pietro Di Marino, Cosima Chiapperino, Francesca Chiara Primavera, Maria Teresa Martino, Davide Brocco, Consiglia Carella, Antonino Grassadonia, Nicola Tinari, & Michele De Tursi. (2022). Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer. OncoTargets and Therapy, 15, 407–410.

Chicago

Pietro Di Marino, Cosima Chiapperino, Francesca Chiara Primavera, Maria Teresa Martino, Davide Brocco, Consiglia Carella, Antonino Grassadonia, Nicola Tinari, and Michele De Tursi. 2022. “Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer.” OncoTargets and Therapy 15 (April): 407–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........05bc834a89a15d1a8d0682b7b23a4687&authtype=sso&custid=ns315887.